by 
Cell culture refers to the removal of cells from an animal or plant and their subsequent growth in an artificial controlled environment. Cells grown outside their natural biological surroundings are cultured cells. Some of the key advantages of cell culture include ease of manipulation, ability to study cells in isolation, capacity to grow cells from small samples and various tissue types, study real-time cellular responses, development of new medicines, vaccines production and research. The global biotechnology and pharmaceutical industries significantly rely on cell culture for developing new drugs, testing drug toxicity and efficacy on cultured cells rather than animals. Additionally, cell culture plays an important role in supporting research on cancer, stem cells and regenerative medicine.
The global Cell Culture Market is estimated to be valued at US$ 19,198.0 Mn in 2023 and is expected to exhibit a CAGR of 7.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the major trends in the cell culture market is the shift towards 3D cell culture. 3D cell culture provides cells in an artificial environment that closely resembles natural tissues when compared to traditional 2D techniques. Use of 3D cell culture enables high-throughput drug screening and disease modeling approaches which is fueling pharmaceutical R&D. Growing stem cell research is also favoring 3D cell culture adoption. Other significant trends include increasing GMP cell culture capabilities to produce cell-based therapies at an industrial scale and use of serum-free and xeno-free cell culture media and reagents to address safety concerns and support translational medicine applications. Rapid advancement of cell culture technologies including microfluidics, bioreactors and organ-on-chip models is expected to further enhance cell culture applications over the forecast period.
Porter’s Analysis
Threat of new entrants: High capital requirements for R&D and manufacturing facilities pose a barrier for new companies.
Bargaining power of buyers: Buyers have moderate bargaining power due to availability of substitutes. However, customized products increase switching costs.
Bargaining power of suppliers: Suppliers of raw materials have low to moderate bargaining power due to availability of substitute materials.
Threat of new substitutes: Threat of substitution is moderate as cell culture technologies face competition from alternative research methods.
Competitive rivalry: Intense competition exists among existing players to gain market share through product innovation and strategic partnerships.
Key Takeaways
The global cell culture market is expected to witness high growth. Regional analysis comprises the North American region dominates the market currently due to presence of major players and availability of advanced research infrastructure. Asia Pacific is expected to grow at the fastest pace during the forecast period with increasing investments in R&D by pharmaceutical players from China, India.
Key players operating in the cell culture market are Corning Incorporated, Merck KGaA, Sartorius AG, BioSpherix, Ltd., Cell Culture Company, LLC, Thermo Fisher Scientific Inc., VWR International LLC, and Lonza. Cell culture products from major players cater to diverse end use industries like biotechnology, pharmaceutical, cosmetics etc. Players are focused on developing innovative 3D cell culture products and services to simulate in vivo conditions and accelerate drug discovery.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.
